secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profusa, Inc. (PFSA)
CIK:        0001859807
Form:       8-K
Filed at:   2026-06-23T17:00:24+00:00
Accession:  0001213900-26-070970
Event type: other
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Profusa shareholders approve reverse stock split, asset acquisition, and equity plan amendments
--------------------------------------------------------------------------------

- Elected Lauren Chung as Class I director with 631,502 FOR votes.
- Approved reverse stock split (1:5 to 1:200) at board's discretion through June 2028.
- Approved issuance of convertible preferred stock and common shares to Bio Insights LLC for PanOmics Assay acquisition.
- Approved potential >19.99% share issuance upon conversion of promissory note to NorthView Sponsor I LLC.
- Approved increase in 2025 Equity and Incentive Plan shares from 100,386 to 795,930.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859807/000121390026070970/0001213900-26-070970-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859807/000121390026070970/ea0295656-8k_profusa.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-070970

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer